Pavel Klein
Physician · Northeast Regional Epilepsy Group
Credentials: · · · · · ·
History
- 2025–Present
- 1989–1990
- 1976–1980
CAMBRIDGE UNIV, CAMBRIDGE
Research
Three patterns of catamenial epilepsy
Epilepsia · 1997 · 340 citations
The Lancet Neurology · 2020 · 283 citations
Review · CNS Drugs · 2021 · 279 citations
13 papers
- GK
11 papers
- AH
9 papers
8 papers
- WR
8 papers
- JF
7 papers
- VB
6 papers
- AR
5 papers
Grants
- 2023–2025
Treatment of Status Epilepticus and Refractory Status Epilepticus with Intravenous Topiramate.
National Institute of Neurological Disorders and Stroke · R43
Contact PI · $702.5K · Prevep, Inc.
- 2021–2024
Network Pharmacology for Epilepsy Prevention
National Institute of Neurological Disorders and Stroke · R43
Contact PI · $700K · Prevep, Inc.
- 2004–2008
Pilot: Levetiracetam to Prevent Post-Traumatic Epilepsy
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.8M · Medstar Health Research Institute
- 2002–2004
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $8.8K · Georgetown University
Clinical trials
- 2017–2020
Treatment of Type 2 Diabetes With Ketogenic Diet
Principal investigator · Unknown
Mid-Atlantic Epilepsy and Sleep Center, LLC
- 2015–2017
Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.
Principal investigator · Terminated · Phase 4
Mid-Atlantic Epilepsy and Sleep Center, LLC
- 2015–2018
Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy
Principal investigator · Unknown · Phase 4
Pavel Klein
- 2014–2016
Levetiracetam, Lacosamide and Ketamine as Adjunctive Treatment of Refractory Status Epilepticus
Principal investigator · Withdrawn · Phase 3
Mid-Atlantic Epilepsy and Sleep Center, LLC